|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/22/2024 |
$4.60 |
$4.81 |
$4.51 |
$4.55 |
283.20K | 04/23/2024 |
$4.57 |
$5.01 |
$4.54 |
$4.77 |
88.20K | 04/24/2024 |
$4.77 |
$4.86 |
$4.44 |
$4.55 |
95.20K | 04/25/2024 |
$4.50 |
$4.50 |
$4.19 |
$4.24 |
130.20K | 04/26/2024 |
$4.25 |
$4.25 |
$4.05 |
$4.16 |
79.70K |
|
Eagle Pharmaceuticals is an integrated pharmaceutical company with research and development, clinical, manufacturing and commercial capabilities. Co.'s products and product portfolio include: BARHEMSYS® (amisulpride for injection), which is for the treatment of postoperative nausea and vomiting; BYFAVO® (remimazolam for injection), which is indicated for the induction and maintenance of procedural sedation; bendamustine ready-to-dilute (RTD) 500ml solution, infused bendamustine RTD, and bendamustine RTD and infused RTD in Japan for Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma; Ryanodex® (dantrolene sodium) for Malignant Hyperthermia; and EA-114 (fulvestrant) for breast cancer. | |
|
Eagle Pharmaceuticals (EGRX) has the following price history information. Looking back at EGRX historical stock prices for the last five trading days, on April 22, 2024, EGRX opened at $4.60, traded as high as $4.81 and as low as $4.51, and closed at $4.55. Trading volume was a total of 283.20K shares. On April 23, 2024, EGRX opened at $4.57, traded as high as $5.01 and as low as $4.54, and closed at $4.77. Trading volume was a total of 88.20K shares. On April 24, 2024, EGRX opened at $4.77, traded as high as $4.86 and as low as $4.44, and closed at $4.55. Trading volume was a total of 95.20K shares. On April 25, 2024, EGRX opened at $4.50, traded as high as $4.50 and as low as $4.19, and closed at $4.24. Trading volume was a total of 130.20K shares. On April 26, 2024, EGRX opened at $4.25, traded as high as $4.25 and as low as $4.05, and closed at $4.16. Trading volume was a total of 79.70K shares.
EGRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Eagle Pharmaceuticals shares, starting with a $10,000 purchase of EGRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$9.88 |
|
End price/share: |
$4.16 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-57.89% |
|
Average Annual Total Return: |
-8.29% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4,208.88 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/22/2024 | $4.55 | 04/23/2024 | $4.77 | 04/24/2024 | $4.55 | 04/25/2024 | $4.24 | 04/26/2024 | $4.16 |
|
|